vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
SYPRIS SOLUTIONS INC is the larger business by last-quarter revenue ($30.3M vs $19.2M, roughly 1.6× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -12.9%, a 6.1% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -9.5%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -7.7%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
APYX vs SYPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $30.3M |
| Net Profit | $-1.3M | $-3.9M |
| Gross Margin | 62.6% | 4.6% |
| Operating Margin | 0.1% | -10.9% |
| Net Margin | -6.8% | -12.9% |
| Revenue YoY | 34.7% | -9.5% |
| Net Profit YoY | 71.9% | -2992.6% |
| EPS (diluted) | — | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $30.3M | ||
| Q3 25 | $12.9M | $28.7M | ||
| Q2 25 | $11.4M | $31.4M | ||
| Q1 25 | $9.4M | $29.5M | ||
| Q4 24 | $14.2M | $33.4M | ||
| Q3 24 | $11.5M | $35.7M | ||
| Q2 24 | $12.1M | $35.5M | ||
| Q1 24 | $10.2M | $35.6M |
| Q4 25 | $-1.3M | $-3.9M | ||
| Q3 25 | $-2.0M | $517.0K | ||
| Q2 25 | $-3.8M | $-2.1M | ||
| Q1 25 | $-4.2M | $-899.0K | ||
| Q4 24 | $-4.6M | $135.0K | ||
| Q3 24 | $-4.7M | $390.0K | ||
| Q2 24 | $-6.6M | $16.0K | ||
| Q1 24 | $-7.6M | $-2.2M |
| Q4 25 | 62.6% | 4.6% | ||
| Q3 25 | 64.4% | 7.2% | ||
| Q2 25 | 62.3% | 8.2% | ||
| Q1 25 | 60.1% | 11.4% | ||
| Q4 24 | 63.0% | 16.1% | ||
| Q3 24 | 60.5% | 16.8% | ||
| Q2 24 | 61.7% | 15.9% | ||
| Q1 24 | 58.1% | 8.1% |
| Q4 25 | 0.1% | -10.9% | ||
| Q3 25 | -6.5% | -6.1% | ||
| Q2 25 | -22.6% | -4.6% | ||
| Q1 25 | -32.4% | -0.4% | ||
| Q4 24 | -21.4% | 3.9% | ||
| Q3 24 | -31.6% | 4.8% | ||
| Q2 24 | -45.7% | 3.6% | ||
| Q1 24 | -64.6% | -3.9% |
| Q4 25 | -6.8% | -12.9% | ||
| Q3 25 | -15.4% | 1.8% | ||
| Q2 25 | -33.2% | -6.5% | ||
| Q1 25 | -44.0% | -3.0% | ||
| Q4 24 | -32.5% | 0.4% | ||
| Q3 24 | -40.9% | 1.1% | ||
| Q2 24 | -54.0% | 0.0% | ||
| Q1 24 | -74.0% | -6.2% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $0.02 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | $-0.19 | $0.00 | ||
| Q1 24 | $-0.22 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $17.8M |
| Total Assets | $66.8M | $107.8M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $37.3M | — |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $17.8M | ||
| Q3 25 | $5.8M | $20.0M | ||
| Q2 25 | $7.3M | $18.7M | ||
| Q1 25 | $10.5M | $19.0M | ||
| Q4 24 | $14.2M | $19.6M | ||
| Q3 24 | $11.0M | $18.2M | ||
| Q2 24 | $14.7M | $19.0M | ||
| Q1 24 | $20.3M | $20.8M |
| Q4 25 | $66.8M | $107.8M | ||
| Q3 25 | $57.4M | $112.5M | ||
| Q2 25 | $58.2M | $105.8M | ||
| Q1 25 | $60.2M | $110.2M | ||
| Q4 24 | $64.8M | $119.4M | ||
| Q3 24 | $60.7M | $121.6M | ||
| Q2 24 | $65.4M | $124.2M | ||
| Q1 24 | $70.7M | $129.0M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-1.1M |
| Free Cash FlowOCF − Capex | $-2.8M | $-1.5M |
| FCF MarginFCF / Revenue | -14.6% | -5.0% |
| Capex IntensityCapex / Revenue | 1.4% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-1.1M | ||
| Q3 25 | $-3.5M | $-178.0K | ||
| Q2 25 | $-1.2M | $1.1M | ||
| Q1 25 | $-702.0K | $-5.5M | ||
| Q4 24 | $-2.9M | $2.3M | ||
| Q3 24 | $-4.4M | $-4.8M | ||
| Q2 24 | $-4.3M | $6.2M | ||
| Q1 24 | $-6.3M | $-1.7M |
| Q4 25 | $-2.8M | $-1.5M | ||
| Q3 25 | $-4.1M | $-390.0K | ||
| Q2 25 | $-1.5M | $941.0K | ||
| Q1 25 | $-757.0K | $-5.5M | ||
| Q4 24 | $-3.2M | $1.9M | ||
| Q3 24 | $-4.6M | $-4.9M | ||
| Q2 24 | $-4.6M | $6.0M | ||
| Q1 24 | $-6.4M | $-2.0M |
| Q4 25 | -14.6% | -5.0% | ||
| Q3 25 | -31.5% | -1.4% | ||
| Q2 25 | -13.2% | 3.0% | ||
| Q1 25 | -8.0% | -18.8% | ||
| Q4 24 | -22.4% | 5.7% | ||
| Q3 24 | -40.0% | -13.8% | ||
| Q2 24 | -38.0% | 16.8% | ||
| Q1 24 | -62.2% | -5.7% |
| Q4 25 | 1.4% | 1.3% | ||
| Q3 25 | 4.0% | 0.7% | ||
| Q2 25 | 2.3% | 0.5% | ||
| Q1 25 | 0.6% | 0.0% | ||
| Q4 24 | 1.7% | 1.2% | ||
| Q3 24 | 1.3% | 0.4% | ||
| Q2 24 | 2.4% | 0.5% | ||
| Q1 24 | 0.3% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | -12.21× | ||
| Q2 24 | — | 385.25× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
